Interfering parameters in the determination of urinary globotriaosylceramide (Gb3) in patients with chronic kidney disease.

CONCLUSION: The Gb3-24:18 isoform ratio is unaffected by several potential influencing variables and may thus be applied for screening for Fabry disease in unselected cohorts of patients presenting with CKD.
PMID: 25857295 [PubMed - as supplied by publisher] (Source: Journal of Nephrology)